Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:49 PM UTC
| NCT Number | NCT05985655 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 230 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | August 13, 2026 (Aug 13, 2026) |
As of October 15, 2026: Clinical trial NCT05985655 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 6 locations across the United States. The study is sponsored by Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05985655 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05985655 was last updated Aug 13, 2026 (August 13, 2026). HelloStudys verifies this status automatically.